Doxorubicin chemotherapy affects intracellular and interstitial nitric oxide concentrations in skeletal muscle

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Cell Biology and Toxicology

• Publication date

  2016-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s10565-016-9325-1PMID 27059331
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Skeletal Muscle an Active Compartment in the Sequestering and Metabolism of Doxorubicin Chemotherapy

  2015cited by this paper
• Acylated and unacylated ghrelin inhibit doxorubicin‐induced apoptosis in skeletal muscle

  2014cited by this paper
• Extracellular Superoxide Dismutase Ameliorates Skeletal Muscle Abnormalities, Cachexia, and Exercise Intolerance in Mice with Congestive Heart Failure

  2014cited by this paper
• Deficient nitric oxide signalling impairs skeletal muscle growth and performance: involvement of mitochondrial dysregulation

  2014cited by this paper
• Tissue retention of doxorubicin and its effects on cardiac, smooth, and skeletal muscle function

  2013cited by this paper
• Carbonyl reductase 1 is an essential regulator of skeletal muscle differentiation and regeneration.

  2013cited by this paper
• Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies.

  2012cited by this paper
• Identification of the molecular basis of doxorubicin-induced cardiotoxicity

  2012cited by this paper
• Dietary inorganic nitrate alleviates doxorubicin cardiotoxicity: mechanisms and implications.

  2012cited by this paper
• Chemotherapy-Induced Weakness and Fatigue in Skeletal Muscle: The Role of Oxidative Stress

  2011cited by this paper
• Exercise protects against doxorubicin-induced markers of autophagy signaling in skeletal muscle.

  2011cited by this paper
• Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma.

  2010cited by this paper
• Decreased Jun-D and myogenin expression in muscle wasting of human cachexia.

  2009cited by this paper
• Direct effects of doxorubicin on skeletal muscle contribute to fatigue

  2009cited by this paper
• Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment

  2009cited by this paper
• Carbonyl Reductase 1 Is a Predominant Doxorubicin Reductase in the Human Liver

  2008cited by this paper
• Protective effects of telmisartan against acute doxorubicin-induced cardiotoxicity in rats.

  2008cited by this paper
• Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity

  2007cited by this paper
• Prospective longitudinal evaluation of doxorubicin‐induced cardiomyopathy in sarcoma patients: A report of the late effects surveillance system (LESS)

  2006cited by this paper
• Use of microdialysis to study interstitial nitric oxide and other reactive oxygen and nitrogen species in skeletal muscle.

  2005cited by this paper
• NF-κB-Mediated MyoD Decay during Muscle Wasting Requires Nitric Oxide Synthase mRNA Stabilization, HuR Protein, and Nitric Oxide Release

  2005cited by this paper
• NF-kappa B-mediated MyoD decay during muscle wasting requires nitric oxide synthase mRNA stabilization, HuR protein, and nitric oxide release.

  2005cited by this paper
• Plasma nitric oxide levels used as an indicator of doxorubicin-induced cardiotoxicity in rats.

  2005cited by this paper
• Doxorubicin Induces Apoptosis in Normal and Tumor Cells via Distinctly Different Mechanisms

  2004cited by this paper
• Endogenous production and exogenous exposure to nitric oxide augment doxorubicin cytotoxicity for breast cancer cells but not cardiac myoblasts.

  2004cited by this paper
• Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity

  2004cited by this paper
• Chemotherapy-Associated Oxidative Stress: Impact on Chemotherapeutic Effectiveness

  2004cited by this paper
• Doxorubicin induces an increase of nitric oxide synthesis in rat cardiac cells that is inhibited by iron supplementation.

  2002cited by this paper
• Doxorubicin inhibits the production of nitric oxide by colorectal cancer cells

  2002cited by this paper
• Physiology of nitric oxide in skeletal muscle.

  2001cited by this paper
• Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study.

  2001cited by this paper
• Doxorubicin-induced Apoptosis Is Associated with Increased Transcription of Endothelial Nitric-oxide Synthase

  2001cited by this paper
• Elevated interstitial adenosine concentrations do not activate the muscle reflex.

  2001cited by this paper
• Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis.

  2000cited by this paper
• Doxorubicin-induced Apoptosis in Endothelial Cells and Cardiomyocytes Is Ameliorated by Nitrone Spin Traps and Ebselen

  2000cited by this paper
• Progressive cardiac dysfunction in adriamycin‐induced cardiomyopathy rats

  2000cited by this paper
• Protective effect of thymoquinone against doxorubicin-induced cardiotoxicity in rats: a possible mechanism of protection.

  2000cited by this paper
• Nitric oxide and platelet aggregation.

  1999cited by this paper
• Cycling and Bioreductive Anticancer Agents Nitric Oxide Synthases Catalyze the Activation of Redox Updated

  1999cited by this paper
• Daunorubicin-induced apoptosis in rat cardiac myocytes is inhibited by dexrazoxane.

  1999cited by this paper
• A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin.

  1999cited by this paper
• Muscle interstitial glucose and lactate levels during dynamic exercise in humans determined by microdialysis.

  1999cited by this paper
• Inducible nitric oxide synthase in skeletal muscle of patients with chronic heart failure.

  1998cited by this paper
• Adenosine concentrations in the interstitium of resting and contracting human skeletal muscle.

  1998cited by this paper
• Analyses of the molecular mechanism of adriamycin-induced cardiotoxicity.

  1997cited by this paper
• Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin.

  1997cited by this paper
• MyoD is required for myogenic stem cell function in adult skeletal muscle.

  1996cited by this paper
• Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants.

  1996cited by this paper
• Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase.

  1994cited by this paper
• Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis.

  1992cited by this paper
• Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.

  1990cited by this paper
• Doxorubicin cardiotoxicity: analysis of prevailing hypotheses

  1990cited by this paper
• Doxorubicin Cardiotoxicity in the Rat: Comparison of Electrocardiogram, Transmembrane Potential, and Structural Effects

  1984cited by this paper
• Effect of adriamycin on DNA, RNA, and protein synthesis in cell-free systems and intact cells.

  1976cited by this paper
• Adriamycin-a review.

  1975cited by this paper
• Dialytrode for long term intracerebral perfusion in awake monkeys.

  1972cited by this paper

• Tumour growth and chemotherapy alter skeletal muscle, cardiac, and hepatic amino acid pools in mice.

  2025cites this paper
• Whole-body exercise following Doxorubicin administration alters skeletal muscle drug accumulation and amino acid pools.

  2025cites this paper
• Examining tissue-level changes in Doxorubicin accumulation and Nitric Oxide formation in skeletal muscle and tumours in a mouse model of breast cancer.

  2025cites this paper
• Mechanistic Insights into Carvedilol's Potential Protection Against Doxorubicin-Induced Cardiotoxicity.

  2024cites this paper
• Chemotherapy-Induced Molecular Changes in Skeletal Muscle

  2023cites this paper
• Nitric Oxide Sensing by a Blue Fluorescent Protein

  2022cites this paper
• Anticancer Drug-Induced Cardiotoxicity: Insights and Pharmacogenetics

  2021cites this paper
• Protective effects of endurance exercise on skeletal muscle remodeling against doxorubicin-induced myotoxicity in mice

  2020cites this paper
• Molecular mechanism involved in cyclophosphamide‐induced cardiotoxicity: Old drug with a new vision

  2019cites this paper
• Doxorubicin chemotherapy affects the intracellular and interstitial free amino acid pools in skeletal muscle

  2018cites this paper
• Cell toxicity mechanism and biomarker

  2018cites this paper